arrow
D

Dan Siskind

Metro South Health
H指数:60
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data

GLP-1受体激动剂启动与精神分裂症和2型糖尿病成人患者精神科住院和急诊就诊风险:一项基于电子健康记录数据的观察性队列研究

2026-10-140
OAAI
A multidisciplinary perspective on digital health interventions in schizophrenia care: Expanding the 2026 Grading of Recommendations, Assessment, Development and Evaluations guidelines

对精神分裂症护理中数字健康干预措施的多学科视角:扩展2026年推荐、评估、制定和评价分级指南

2026-09-280
PRE
A Summary for Non-Psychiatrists of the Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development and Evaluations (GRADE) Guidelines for the Management of Schizophrenia

非精神科医师对《澳大利亚和新西兰精神病学杂志》关于精神分裂症管理的GRADE指南(推荐、评估、制定和评价分级)的概述

2026-09-100
PRE
Hospitalisation and mortality outcomes after second COVID-19 vaccination among Australians living with severe mental illness: Findings from a matched case–control study using national data linkage

澳大利亚严重精神疾病患者第二次接种COVID-19疫苗后的住院和死亡结局:基于国家数据关联的匹配病例对照研究结果

2026-08-200
PRE
Clinical Practice Guideline on the Pharmacological Management of Antipsychotic-Related Dyslipidemia

抗精神病药物相关血脂异常的药物治疗临床实践指南

2026-08-030
OAAI
Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations

澳大利亚和新西兰精神分裂症初始躯体健康评估:2026年建议

2026-04-260
OA